Leberfett-quantifizierung: Brauchen wir das?

• References

• 1 Eslam M, Newsome PN, Sarin SK. et al. A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement. J Hepatol 2020; 73 (01) 202-209
• 2 Vitale A, Svegliati-Baroni G, Ortolani A. et al. Epidemiological trends and trajectories of MAFLD-associated hepatocellular carcinoma 2002–2033: the ITA.LI.CA database. Gut 2023; 72 (01) 141-152
• 3 Ferri S, Stefanini B, Mulazzani L. et al. Very Low Alcohol Consumption Is Associated with Lower Prevalence of Cirrhosis and Hepatocellular Carcinoma in Patients with Non-Alcoholic Fatty Liver Disease. Nutrients 2022; 14 (12) 2493
• 4 Brunt EM, Clouston AD, Goodman Z. et al. Complexity of ballooned hepatocyte feature recognition: Defining a training atlas for artificial intelligence-based imaging in NAFLD. J Hepatol 2022; 76 (05) 1030-1041
• 5 Brunt EM, Tiniakos DG. Histopathology of nonalcoholic fatty liver disease. World J Gastroenterol 2010; 16 (42) 5286-5296
• 6 Bauer DJ, Matic V, Mare R. et al. Point Shear Wave Elastography by ElastPQ for Fibrosis Screening in Patients with NAFLD: A Prospective, Multicenter Comparison to Vibration Controlled Elastography. Ultraschall in Med 2022;
• 7 Ferraioli G, Berzigotti A, Barr RG. et al. Quantification of Liver Fat Content with Ultrasound: A WFUMB Position Paper. Ultrasound Med Biol 2021; 47 (10) 2803-2820
• 8 Labyed Y, Milkowski A. Novel Method for Ultrasound-Derived Fat Fraction Using an Integrated Phantom. J Ultrasound Med 2020; 39 (12) 2427-2438 . Epub 2020 Jun 11. PMID: 32525261
• 9 Pericàs JM, Tacke F, Anstee QM. et al. Platform trials to overcome major shortcomings of traditional clinical trials in non-alcoholic steatohepatitis? Pros and cons. J Hepatol 2023; 78 (02) 442-447
• 10 Selvaraj EA, Mózes FE, Jayaswal ANA. et al. Diagnostic accuracy of elastography and magnetic resonance imaging in patients with NAFLD: A systematic review and meta-analysis. J Hepatol 2021; 75 (04) 770-785
• 11 Pennisi G, Enea M, Pandolfo A. et al AGILE 3+ Score for the Diagnosis of Advanced Fibrosis and for Predicting Liver-related Events in NAFLD. Clin Gastroenterol Hepatol 2022; S1542-3565(22)00646-2
• 12 Petta S, Maida M, Macaluso FS. et al. The severity of steatosis influences liver stiffness measurement in patients with nonalcoholic fatty liver disease. Hepatology 2015; 62 (04) 1101-1110
• 13 Petta S, Wong VW, Cammà C. et al. Improved noninvasive prediction of liver fibrosis by liver stiffness measurement in patients with nonalcoholic fatty liver disease accounting for controlled attenuation parameter values. Hepatology 2017; 65 (04) 1145-1155
• 14 Dioguardi Burgio M, Imbault M, Ronot M. et al. Ultrasonic Adaptive Sound Speed Estimation for the Diagnosis and Quantification of Hepatic Steatosis: A Pilot Study. Ultraschall in Med 2019; 40 (06) 722-733